Holen Sie sich die Stockscreener-App
4.15
0.95%
-0.04
Handel nachbörslich:
4.15
Schlusskurs vom Vortag:
$4.19
Offen:
$4.25
24-Stunden-Volumen:
7,422
Relative Volume:
0.66
Marktkapitalisierung:
$47.99M
Einnahmen:
$10.96M
Nettoeinkommen (Verlust:
$-7.02M
KGV:
-6.5873
EPS:
-0.63
Netto-Cashflow:
$-3.72M
1W Leistung:
+4.27%
1M Leistung:
-0.81%
6M Leistung:
-34.54%
1J Leistung:
-20.19%
1-Tages-Spanne:
$4.05
$4.25
1-Wochen-Bereich:
$4.00
$4.58
52-Wochen-Spanne:
$3.61
$6.99
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Firmenname
Collplant Biotechnologies Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CLGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| CLGN | 4.15 | 47.99M | 10.96M | -7.02M | -3.72M | -0.63 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-02-17 | Eingeleitet | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Aktie (CLGN) Neueste Nachrichten
CollPlant (CLGN) to Report Q3 2024 Earnings on Nov 27: Conference Call Details | CLGN Stock News - StockTitan
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - Quantisnow
Companies Like CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Invest In Growth - Yahoo Finance
Collplant stock hits 52-week low at $3.61 amid market challenges - Investing.com Australia
500: Something went wrong - Investing.com India
Collplant stock hits 52-week low at $3.75 amid market challenges - Investing.com Australia
EF Hutton Initiates Coverage of CollPlant Biotechnologies (CLGN) with Buy Recommendation - MSN
Collplant stock hits 52-week low at $4.05 amid market challenges - Investing.com India
Collplant stock hits 52-week low at $4.05 amid market challenges By Investing.com - Investing.com South Africa
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Update - Defense World
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Up 5.3% in September - MarketBeat
Benjamin F. Edwards & Company Inc. Sells 10,690 Shares of CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) - Defense World
CollPlant Shareholders Approve Key Proposals - TipRanks
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Growth in Short Interest - MarketBeat
3D Bioprinting Market valued at USD 1.41 billion in 2024 | ExactitudeConsultancy - GlobeNewswire
CollPlant (CLGN), Stratasys Initiate Study for Breast Implants - MSN
CollPlant and Stratasys Launch Pre-clinical Trial for Regenerative 3D-Printed Breast Implants - 3DPrint.com
The Stratasys’ Origin® printer to be tested for CollPlant’s 3D-printed breast implants - 3d adept media
HC Wainwright Weighs in on CollPlant Biotechnologies Ltd.'s Q3 2024 Earnings (NASDAQ:CLGN) - MarketBeat
Head-To-Head Analysis: Envoy Medical (NASDAQ:COCH) and CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World
HC Wainwright Weighs in on CollPlant Biotechnologies Ltd.’s Q3 2024 Earnings (NASDAQ:CLGN) - Defense World
FY2027 EPS Estimates for CollPlant Biotechnologies Ltd. Reduced by HC Wainwright (NASDAQ:CLGN) - MarketBeat
HC Wainwright Research Analysts Cut Earnings Estimates for CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) - Defense World
Global Tooth Regeneration Market Size To Worth USD 8.20 Billion By 2033 | CAGR Of 6.18% - GlobeNewswire Inc.
CollPlant Schedules Shareholder Meeting - Investing.com India
CollPlant Schedules Shareholder Meeting By Investing.com - Investing.com Australia
Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies - Benzinga
CollPlant Biotechnologies’ (CLGN) Buy Rating Reaffirmed at HC Wainwright - Defense World
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: CollPlant Biotechnologies reports Q2 2024 financials By Investing.com - Investing.com Australia
CollPlant Biotechnologies Ltd (CLGN) Q2 2024 Earnings Call Trans - GuruFocus.com
Q2 2024 Collplant Biotechnologies Ltd Earnings Call Transcript - GuruFocus.com
CollPlant Announces Upcoming Shareholder Meeting - TipRanks
Collplant stock hits 52-week low at $4.1 amid market challenges - Investing.com
Even after rising 10% this past week, CollPlant Biotechnologies (NASDAQ:CLGN) shareholders are still down 71% over the past three years - Yahoo Finance
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - Nasdaq
We're Interested To See How CollPlant Biotechnologies (NASDAQ:CLGN) Uses Its Cash Hoard To Grow - Simply Wall St
CollPlant and Stratasys launch pre-clinical study for 3D implants - Investing.com India
CollPlant Biotechnologies (FRA:CPT) Earnings per Share (Dil - GuruFocus.com
CollPlant Biotechnologies (FRA:CPT) Cash Flow for Lease Fin - GuruFocus.com
CollPlant Biotechnologies (FRA:CPT) Market Cap : €48.54 Mil (As of Aug. 19, 2024) - GuruFocus.com
CollPlant and Stratasys announce pre-clinical study for regenerative breast implants - Med-Tech Innovation
Stratasys and CollPlant commence pre-clinical study for 3D printed regenerative breast implants - TCT Magazine
CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants - Lelezard
CollPlant Biotechnologies (FRA:CPT) Cash Flow from Financin - GuruFocus.com
CollPlant Biotechnologies (FRA:CPT) Cash-to-Debt : 7.69 (As of Mar. 2024) - GuruFocus.com
CollPlant Biotechnologies (FRA:CPT) Machinery, Furniture, E - GuruFocus.com
CLGN (CollPlant Biotechnologies) Debt-to-Revenue : 7.70 (As of Mar. 2024) - GuruFocus.com
CLGN (CollPlant Biotechnologies) EV-to-Revenue : 3.11 (As of Aug. 18, 2024) - GuruFocus.com
CLGN (CollPlant Biotechnologies) 14-Day RSI : 48.58 (As of Aug. 18, 2024) - GuruFocus.com
Finanzdaten der Collplant Biotechnologies Ltd-Aktie (CLGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):